Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Non-cash operating lease expense Noncash Operating Lease Expense Noncash Operating Lease Expense Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Carrying Value Reported Value Measurement [Member] Document Fiscal Year Focus Document Fiscal Year Focus Customer A Customer A [Member] Customer A [Member] Adjustment to Compensation, Amount Adjustment to Compensation Amount Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Common stock, $0.01 par value; 500,000,000 authorized shares, 218,281,059 and 214,255,853 issued and outstanding shares at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Accrued compensation and employee related costs Employee-related Liabilities, Current Royalty Financing Agreement interest expense Royalty Agreements Royalty Agreements [Member] Leases Lessee, Finance Leases [Text Block] Restatement Determination Date Restatement Determination Date Amendment Flag Amendment Flag Schedule of Earnings Per Share, Basic and Diluted [Table] Schedule of Earnings Per Share, Basic and Diluted [Table] Schedule of Earnings Per Share, Basic and Diluted [Table] Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Payments of finance lease principal Finance Lease, Principal Payments Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Probabilities of success Measurement Input, Probability Of Success [Member] Measurement Input, Probability Of Success Leases [Abstract] Cost, Product and Service [Extensible Enumeration] Cost, Product and Service [Extensible Enumeration] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Revenue Interest Payments payable Revenue Interest Payments Payable Revenue Interest Payments Payable Accrued milestone payment to AstraZeneca Accrued Milestone Payment, Current Accrued Milestone Payment, Current Property, Plant, and Equipment [Abstract] Entity Address, State or Province Entity Address, State or Province Brensocatib external R&D expenses Brensocatib [Member] Brensocatib Licensing Agreements Licensing Agreements [Member] Foreign currency translation (losses) gains Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Unvested PSUs outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted average basic common shares outstanding (in shares) Weighted average common shares used in calculation of basic net loss per share (in shares) Weighted Average Number of Shares Outstanding, Basic Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Number of reportable segment Number of Reportable Segments Total current liabilities Liabilities, Current Work-in-process Inventory, Work in Process, Net of Reserves Term Loans Term Loans contractual interest expense Term Loan [Member] Term Loan Concentration Risk [Table] Concentration Risk [Table] Comprehensive loss: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Entity Address, City or Town Entity Address, City or Town Stock-Based Compensation Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Inducement stock options granted to new employees (in shares) Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross Gross number of inducement share options (or share units) granted during the period. Intangibles, net Beginning balance Ending balance Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Revenue Interest Payments paid and payable Payments for Royalties Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Investment income Investment income Investment Income, Nonoperating US UNITED STATES Concentration Risk Type [Axis] Concentration Risk Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recent Accounting Pronouncements (Not Yet Adopted) New Accounting Pronouncements, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Land Land [Member] Schedule of Segment Loss, Including Significant Segment Expenses Segment Reporting [Table Text Block] Amortization of debt issuance costs Amortization of issuance costs Amortization of Debt Issuance Costs Use of Estimates Use of Estimates, Policy [Policy Text Block] Product Revenues, Net Revenue from Contract with Customer [Policy Text Block] Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Accounts Payable and Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Royalty Financing Agreement [Roll Forward] Royalty Financing Agreement [Roll Forward] Royalty Financing Agreement Total Long-Term Debt Fixed Assets, Net Property, Plant, and Equipment [Text Block] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Principal Face amount Debt Instrument, Face Amount Shareholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name Debt term (in months) Debt Instrument, Term Effective interest rate Debt Instrument, Interest Rate, Effective Percentage 2019 Incentive Plan 2019 Incentive Plan [Member] 2019 Incentive Plan [Member] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Purchase of marketable securities Purchase of marketable securities Payments to Acquire Marketable Securities Accumulated other comprehensive (loss) gain Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Shares of common stock, maximum authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Operating lease liabilities Operating Lease, Liability, Current Schedule of Fixed Assets Property, Plant, and Equipment [Table Text Block] Statement of Comprehensive Income [Abstract] Finance lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Name Outstanding Recovery, Individual Name Net loss per share: Earnings Per Share [Abstract] Maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] 2018 ESPP Employee Stock Purchase Plan 2018 [Member] Employee Stock Purchase Plan 2018 [Member] Schedule of Reconciliation of the Weighted Average Number of Common Shares Used to Compute Basic and Diluted Net Loss Per Share Schedule of Weighted Average Number of Shares [Table Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Geographical [Domain] Geographical [Domain] Schedule of Interest Expense Related to Debt and Finance Leases Interest Income and Interest Expense Disclosure [Table Text Block] Purchase of fixed assets Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation expense related to unvested stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Income Tax Disclosure [Abstract] Amortization of debt issuance costs Amortization of Debt Issuance Costs and Discounts Royalty financing non-cash interest expense Other Noncash Expense Concentration Risk [Line Items] Concentration Risk [Line Items] Payout, percent Share-Based Payment Arrangement, Nonvested Award, Pay Out, Percent Share-Based Payment Arrangement, Nonvested Award, Pay Out, Percent Term Loans Long-Term Debt, Gross Credit Facility [Domain] Credit Facility [Domain] Operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Weighted average diluted common shares outstanding (in shares) Weighted average common shares outstanding used in calculation of diluted net loss per share (in shares) Weighted Average Number of Shares Outstanding, Diluted R&D compensation and benefit-related expenses Labor And Related Expense, Research And Development Labor And Related Expense, Research And Development Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Estimated Useful Life (years) Property, Plant, and Equipment, Useful Life Underlying Security Market Price Change Underlying Security Market Price Change, Percent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Other assets Increase (Decrease) in Other Noncurrent Assets Revenue from Contract with Customer [Abstract] Manufacturing equipment Manufacturing Equipment [Member] Manufacturing Equipment Inducement total authorized for grant (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Inducement Shares Authorized Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Inducement Shares Authorized Schedule of Earnings Per Share, Basic and Diluted [Line Items] Schedule of Earnings Per Share, Basic and Diluted [Line Items] [Line Items] for Schedule of Earnings Per Share, Basic and Diluted [Table] 0.75% Convertible Senior Notes Due 2028 Zero Point Seven Five Percent Convertible Senior Note Due 2028 [Member] Zero Point Seven Five Percent Convertible Senior Note Due 2028 Award Timing Predetermined Award Timing Predetermined [Flag] Intangible Asset, Goodwill and Other [Abstract] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Schedule of Percentage of Gross Product Revenue Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Fair Value Measurements Fair Value of Financial Instruments, Policy [Policy Text Block] Effect of dilutive securities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements All Executive Categories All Executive Categories [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share SG&A compensation and benefit-related expenses Labor And Related Expense, Selling, General And Administrative Expense Labor And Related Expense, Selling, General And Administrative Expense Depreciation Depreciation Plan Name [Domain] Plan Name [Domain] Customer C Customer C [Member] Customer C [Member] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Accrued technical operation expenses Accrued Technical Operation Expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for technical operation expenses. Proceeds of sale of priority review voucher obligated to pay to equity holders, percentage Proceeds Of Sale Of Priority Review Voucher Obligated To Pay To Equity Holders, Percentage Proceeds Of Sale Of Priority Review Voucher Obligated To Pay To Equity Holders, Percentage Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment Reporting Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Accrued professional fees Accrued Professional Fees Liabilities Liabilities [Abstract] Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Shares issued upon milestone achievements (in shares) Business Combination, Contingent Consideration, Equity Interest Issued And Issuable, Number Of Shares Business Combination, Contingent Consideration, Equity Interest Issued And Issuable, Number Of Shares Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Building Building [Member] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Proceeds from issuance of common stock, net Proceeds from Issuance of Common Stock Common stock, authorized shares (in shares) Common Stock, Shares Authorized Intangible assets estimated useful life (in years) Intangible Asset, Finite-Lived, Useful Life Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Schedule of Carrying Value of Term Loan Balance Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Exercise Price Award Exercise Price Investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segment Reporting [Line Items] Segment Reporting [Line Items] AlgaeneX AlgaeneX, Inc. [Member] AlgaeneX, Inc. Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Debt Debt Disclosure [Text Block] Proceeds from royalty financing Proceeds From Royalty Financing Proceeds From Royalty Financing Royalty Financing Agreement Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block] Debt issuance costs, net Debt Issuance Costs, Net Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Secured Debt Secured Debt [Member] Accretion of discount on marketable securities, net Accretion Of Debt Discount, Marketable Securities Accretion Of Debt Discount, Marketable Securities Total operating expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Interest rate (as a percent) Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Total shareholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Customer B Customer B [Member] Customer B [Member] Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Shares issued in acquisition (in shares) Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Lenders fees and deal expenses Debt Instrument, Fee Amount Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Insider Trading Policies and Procedures [Line Items] Options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] PSUs Performance Shares [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Deferred tax benefit Deferred Income Tax Expense (Benefit) Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Selling, general and administrative Selling, General and Administrative Expense Stock Options, RSUs, PSUs and ESPP Stock Options, Restricted Stock Units, Performance Stock Units And ESPP [Member] Stock Options, Restricted Stock Units, Performance Stock Units And ESPP Proceeds from royalty financing agreement, net Proceeds From Royalty Financing Agreement, Net Proceeds From Royalty Financing Agreement, Net Percentage of outstanding shares Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Business Combination [Domain] Business Combination [Domain] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of operating segment Number of Operating Segments Potentially dilutive securities excluded from computations of diluted weighted-average shares outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount RSUs RSUs Restricted Stock Units (RSUs) [Member] Schedule of Potentially Dilutive Securities Excluded from Computations of Diluted Weighted Average Common Shares Outstanding Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Less: accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Business Combination [Axis] Business Combination [Axis] Equity [Abstract] Issuance of common stock for Business Acquisition milestone achievement Stock Issued During Period, Value, Contingent Payments For Business Acquisitions Stock Issued During Period, Value, Contingent Payments For Business Acquisitions Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation TPIP external R&D expenses TPIP [Member] TPIP Brensocatib Global Net Sales Brensocatib Global Net Sales [Member] Brensocatib Global Net Sales 2026 Long-Term Debt, Maturity, Remainder of Fiscal Year Shareholders’ equity: Equity, Attributable to Parent [Abstract] Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Finance lease liabilities, long-term Finance Lease, Liability, Noncurrent Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Rollforward of Intangible Assets Intangible Asset, Finite-Lived [Table Text Block] Floor interest rate Debt Instrument, Basis Spread on Variable Rate City Area Code City Area Code Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Accrued French rebate payable Contract with Customer, Refund Liability, Current Customer D Customer D [Member] Customer D All Individuals All Individuals [Member] Schedule of Geographic Summary of Product Revenues, Net Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block] Name Forgone Recovery, Individual Name Finished goods Inventory, Finished Goods, Net of Reserves Contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Intangibles, Net and Goodwill Intangible Asset [Text Block] Statement [Line Items] Statement [Line Items] Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Common stock shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Convertible debt contractual interest expense Convertible Debt [Member] Interest expense Total interest expense Interest expense Interest Expense, Nonoperating Schedule of Aggregate Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Other external R&D expenses Other [Member] Other Contingent Consideration Contingent Consideration [Member] Contingent Consideration Net proceeds from issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] 2028 Long-Term Debt, Maturity, Year Two Total stock-based compensation expense Share-Based Payment Arrangement, Expense Measurement Basis [Axis] Measurement Basis [Axis] Marketable securities Marketable Securities, Current Other long-term liabilities Other Liabilities, Noncurrent Goodwill Goodwill Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Issuance of common stock for exercise of stock options, vesting of RSUs and PSUs, and ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Payables and Accruals [Abstract] Average sales prices of publicly disclosed priority review voucher sales obligated to pay equity holders, percentage Average Sales Prices Of Publicly Disclosed Priority Review Voucher Sales Obligated To Pay Equity Holders, Percentage Average Sales Prices Of Publicly Disclosed Priority Review Voucher Sales Obligated To Pay Equity Holders, Percentage Accumulated Deficit Retained Earnings [Member] Operating lease liabilities, long-term Operating Lease, Liability, Noncurrent Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Schedule of Unobservable Inputs in Valuation of Contingent Consideration Liabilities and Rollforward of Valuation of Deferred and Contingent Consideration Liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, outstanding shares (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Diluted net loss per share (in dollars per share) Diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Amortization of intangible assets Amortization of intangible assets Amortization Intangible Asset, Finite-Lived, Amortization Expense Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Research and development Research and Development Expense Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] 2029 Long-Term Debt, Maturity, Year Three Number of quarterly payments Debt Instrument, Number Of Quarterly Payments Debt Instrument, Number Of Quarterly Payments Additions Intangible Asset, Finite-Lived, Acquired Share-Based Payment Arrangement [Abstract] Financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Product revenues, net Revenue from Contract with Customer, Excluding Assessed Tax Fixed assets, net Fixed assets, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Interest payments Debt Instrument, Periodic Payment, Interest Inventory Inventory Disclosure [Text Block] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Issuance of common stock for exercise of stock options, vesting of RSUs and PSUs, and ESPP Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Number of commercial products Number Of Commercial Products Number Of Commercial Products Fair Value Estimate of Fair Value Measurement [Member] Product Revenues, Net Revenue from Contract with Customer [Text Block] Net proceeds from issuance of common stock Stock Issued During Period, Value, New Issues Construction in progress Construction in Progress [Member] Inventory Increase (Decrease) in Inventories Segment Reporting [Table] Segment Reporting [Table] Shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Schedule of Future Principal Repayments of Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Current contingent consideration Contingent consideration Business Combination, Contingent Consideration, Liability, Current Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Office equipment Office Equipment [Member] Operating loss Operating Income (Loss) 2025 Inducement Plan 2025 Inducement Plan [Member] 2025 Inducement Plan Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Interest payable Debt Instrument, Percent Of Interest Payable Debt Instrument, Percent Of Interest Payable Lease cost, future right-of-use asset Unrecorded Unconditional Purchase Obligation Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Anti-dilutive securities excluded from computations of diluted weighted-average common shares outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Issuance of common stock for Business Acquisition milestone achievement (in shares) Stock Issued During Period, Shares, Contingent Payments For Business Acquisitions Stock Issued During Period, Shares, Contingent Payments For Business Acquisitions Common stock, issued shares (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Accrued royalty and milestones payable Royalty financing liability Accrued Royalties, Current Debt instrument additional amount Debt Instrument, Increase (Decrease), Net Other segment items Other Cost and Expense, Operating Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Cash paid for income taxes Income Tax Paid, after Refund Received BRINSUPRI BRINSUPRI [Member] BRINSUPRI Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Finance lease liabilities Finance Lease, Liability, Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Accounts payable and accrued liabilities Total accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Entity Small Business Entity Small Business Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Marketable securities Marketable Securities Document Type Document Type Unrecognized tax benefits, interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Payments of principal of 0.75% convertible senior notes due 2028 Repayments of Convertible Debt Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Royalty financing agreement Royalty Financing Agreement liability - beginning balance Royalty Financing Agreement liability - ending balance Royalty Financing Agreement Accrued Royalties Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Remaining lease term Lease, Remaining Lease Term Lease, Remaining Lease Term Fixed assets, gross Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Amortization of intangible assets, 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Finite-lived Intangible Assets [Roll Forward] Intangible Asset, Finite-Lived [Roll Forward] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Finance lease amortization expense Finance Lease, Right-of-Use Asset, Amortization Contingent Consideration Business Combination [Policy Text Block] Furniture and fixtures Furniture and Fixtures [Member] Liabilities and shareholders’ equity Liabilities and Equity [Abstract] Royalty maximum Debt Instrument, Royalty Payable Debt Instrument, Royalty Payable Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Payment of AZ milestone Payment Of Milestone Payment Of Milestone Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis and Carrying Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Inventory Inventory Inventory, Net Equity Award [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Finance lease interest expense Finance Lease, Interest Expense Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Contingent Consideration (Level 3 Liabilities) Fair Value, Inputs, Level 3 [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] PARI milestones PARI [Member] PARI Amortization of intangible assets, 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Development and regulatory milestones Development And Regulatory Milestones [Member] Development And Regulatory Milestones PEO Name PEO Name Motus Motus Biosciences, Inc. [Member] Motus Biosciences, Inc. Geographical [Axis] Geographical [Axis] Leasehold improvements Leasehold Improvements [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Asset, Class [Axis] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Other assets Other Assets Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Interest expense Interest expense recognized Interest Expense, Debt Reportable Segment Reportable Segment [Member] Reportable Segment Liability Class [Axis] Liability Class [Axis] Exit fee payment Debt Instrument, Exit Fee Payment, Percent Debt Instrument, Exit Fee Payment, Percent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Acquired ARIKAYCE R&D Acquired Research And Development [Member] Acquired Research And Development Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Other accrued liabilities Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] The Company and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Amortization of intangible assets, 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Fee paid Debt Instrument, Fee Paid, Percent Debt Instrument, Fee Paid, Percent Schedule of Activity of Royalty Financing Agreement Schedule of Debt [Table Text Block] Issuance of common stock upon conversion of convertible notes (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Customer [Domain] Customer [Domain] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Leases Lessee, Operating Leases [Text Block] 2027 Long-Term Debt, Maturity, Year One Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic net loss per share (in dollars per share) Basic (in dollars per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] S. Nicole Schaeffer [Member] S. Nicole Schaeffer Total current assets Assets, Current Tranche B Term Loan Tranche B Term Loan [Member] Tranche B Term Loan Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Debt, long-term Long-Term Debt, Excluding Current Maturities Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Unrealized loss on marketable securities Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Change in fair value of contingent consideration Change in fair value of contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Marketable securities Debt Securities, Available-for-Sale Contingent consideration Business Combination, Contingent Consideration, Liability Fair Value Measurement [Domain] Fair Value Measurement [Domain] Rent expense charged to operations Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] International Non-US [Member] Concentration risk, percentage Concentration Risk, Percentage Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Awards Adjustments Equity Awards Adjustments [Member] Accrued clinical trial expenses Accrued Clinical Trial Expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical trial expenses. Development Milestone Development Milestone [Member] Development Milestone Total liabilities and shareholders’ equity Liabilities and Equity Variable lease, cost Variable Lease, Cost Computer hardware and software Computer Hardware And Software [Member] Computer Hardware And Software Common stock options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Other liabilities Increase (Decrease) in Other Operating Liabilities Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Inventory Disclosure [Abstract] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Other (expense) income, net Other Nonoperating Income (Expense) Amortization of intangible assets, 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three Amortization of intangible assets, remainder of 2026 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Total debt interest expense Interest Expense, Excluding Finance Lease Interest Expense Interest Expense, Excluding Finance Lease Interest Expense Royalty percentage Debt Instrument, Royalty, Stated Percentage Debt Instrument, Royalty, Stated Percentage Property, Plant and Equipment, Type [Domain] Long-Lived Asset, Class [Domain] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Issuance of common stock upon conversion of convertible notes Stock Issued During Period, Value, Conversion of Convertible Securities Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Adjustment to Compensation: Adjustment to Compensation [Axis] Accrued sales allowances and related costs Accrued Sales Allowances And Related Costs Accrued Sales Allowances And Related Costs Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Tranche A Term Loan Tranche A Term Loan [Member] Tranche A Term Loan Acquired IPR&D In Process Research and Development [Member] Credit Facility [Axis] Credit Facility [Axis] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Sales Revenue, Product Line Revenue, Product and Service Benchmark [Member] Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable and other accrued operating expenses Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Number of publicly disclosed sales used to determine average sales price owed to equity holders Number Of Publicly Disclosed Sales Used To Determine Average Sales Price Owed To Equity Holders Number Of Publicly Disclosed Sales Used To Determine Average Sales Price Owed To Equity Holders Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Lab equipment Equipment [Member] ARIKAYCE Global Net Sales ARIKAYCE Global Net Sales [Member] ARIKAYCE Global Net Sales Name Trading Arrangement, Individual Name Unrecognized compensation expense related to unvested RSU awards Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and Cash Equivalent Raw materials Inventory, Raw Materials, Net of Reserves Year Ending December 31: Long-Term Debt, Fiscal Year Maturity [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount 2030 and thereafter Long-Term Debt, Maturity, After Year Four Long-Term Debt, Maturity, After Year Four Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Current assets: Assets, Current [Abstract] ARIKAYCE ARIKAYCE external R&D expenses ARIKAYCE [Member] ARIKAYCE Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Depreciation Depreciation, Nonproduction Provision for income taxes Income Tax Expense (Benefit) Effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Customer Concentration Risk Customer Concentration Risk [Member] Convertible notes Convertible Notes Payable [Member] Cost of product revenues (excluding amortization of intangible assets) Cost of Product and Service Sold Award Timing Method Award Timing Method [Text Block] Net increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Debt discount, net Royalty issuance costs, unamortized - beginning balance Royalty issuance costs, unamortized - ending balance Unamortized Debt Issuance Expense AstraZeneca milestones AstraZeneca [Member] AstraZeneca Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from exercise of stock options and ESPP Proceeds from Stock Options Exercised PRV milestone Priority Review Voucher Milestone [Member] Priority Review Voucher Milestone Paid-in-kind interest capitalized Accumulated Capitalized Interest Costs Proceeds from loans Proceeds from Loans Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Product [Member]